1. reliminary antimicrobial screening of Cladosporium extracts
In the current study, the crude extracts of 212 Cladosporium species at a concentration of 1 mg/ml (W/V) in Dimethyl Sulfoxide (DMSO) were tested for their antimicrobial activity against 15 microorganisms including Gram-positive bacteria, Gram-negative bacteria, Candida and filamentous fungi. The results revealed that 12/212 (5.66%) crude extract have antimicrobial activities recovered from 6 different Cladosporium species including C. asterinae (1 strain), C. chlamydosporis (1 strain), C. cladosporioides (5 strains), C. herbarum (2 strains), C. oxysporum (2 strains) and C. uredinicola (1 strain), as illustrated in Figure (1).
Ethyl acetate extracts (1mg/ml) of Cladosporium species exhibited varied antimicrobial activities in which, a strong antimicrobial activity was observed with C. oxysporum HMA-M2 ethyl acetate crude extract, that was active against 10 of tested bacterial and fungal strains, in which its peak antimicrobial activity was observed against C albicans ATCC 10231 (30 ± 1.5 mm), followed by S. aureus ATCC 25923 (28 ± 1.5 mm) and E. coli ATCC 20836 (26.5 ± 1.5 mm) while P. aeruginosa (clinical isolate) was resistant. In addition, C. cladosporioides HMA-285 ethyl acetate crude extract that were active against 8 of tested bacterial and fungal strains, in which its peak antimicrobial activity was observed against S. aureus ATCC 25923 (25 ± 1 mm), followed by A. alternate CBS 154.14 (22 ± 1 mm) while P. aeruginosa (clinical isolate) was resistant. C. herbarum HMA-N9 ethyl acetate crude extract that were active against 8 of tested bacterial and fungal strains, in which in which its maximum antimicrobial activity was observed against by C albicans ATCC 10231 (24 ± 1.5 mm), followed by B. cereus ATCC 6633 (21 ± 1 mm).
Moderate antimicrobial activity was noticed with C. asterinae HMA-300, ethyl acetate crude extracts that was active against 6 of tested bacterial and fungal strains, in which its highest antimicrobial activity was observed against by C albicans ATCC 10231 (18 ± 1 mm), followed by C tropicalis ATCC 13803 (19 ± 1 mm). in addition, C. cladosporioides HMA-232 that showed highest activity against S epidemidis ATCC 12228 (27 ± 0.5), followed by C albicans ATCC 10231 (25 ± 0.5). Likewise, C. cladosporioides HMA-407 where the maximum activity was observed against S. aureus ATCC 25923 (23.6 ± 1.5).
Whereas, mild antimicrobial activity was noticed in C. herbarum HMA-36, ethyl acetate crude extracts that was active against 6 of tested bacterial and fungal strains, in which its highest antimicrobial activity was observed against S epidemidis ATCC 12228 (19.3 ± 1) followed by S. aureus ATCC 25923 (17 ± 0.5). Additionally, C. oxysporum HMA-10 exhibited top antimicrobial activity against C albicans ATCC 10231 (30 ± 1.8), followed by S epidemidis ATCC 12228 (25 ± 1.4). Furthermore, C. oxysporum HMA-13 and C. cladosporioides HMA-713 crude extracts that were active against 5 of tested bacterial and fungal strains.
Weak antimicrobial activity, was observed with C. uredinicola HMA-59, that were active against 4 of tested bacterial and fungal strains, it showed maximum activity against S. aureus ATCC 25923 (18 ± 0.5) and S epidemidis ATCC 12228 (17 ± 1). In addition, C. oxysporum HMA-221 ethyl acetate crude extract that revealed highest activity against K pneumonia ATCC 13883 (19 ± 15) and S epidemidis ATCC 12228 (18.5 ± 0.5), as illustrated in Table (2).
Table 2
Antimicrobial activity of 1 mg/ ml of Cladosporium crude extracts showing inhibition zone diameter (mm).
Microbial strains
|
C. asterinae HMA-300
|
C. chlamydosporis HMA-13
|
C. cladosporioides HMA-221
|
C. cladosporioides HMA-232
|
C. cladosporioides HMA-285
|
C. cladosporioides HMA-407
|
C. cladosporioides HMA-713
|
C. herbarum HMA-36
|
C. herbarum HMA-N9
|
C. oxysporum HMA-10
|
C. oxysporum HMA-M2
|
C. uredinicola HMA-59
|
positive control
|
Negative control DMSO
|
Chloramphenicol (30 µg)
|
Fluconazole (µg)
|
S. aureus ATCC 25923
|
13 ± 0.5
|
17 ± 1.78
|
16 ± 0.5
|
18 ± 0.5
|
25 ± 1
|
23.6 ± 1.5
|
22.5 ± 1.5
|
17 ± 0.5
|
19 ± 1.5
|
22.5 ± 0.7
|
28 ± 1.5
|
18 ± 0.5
|
31
|
-
|
0
|
S. epidemidis ATCC 12228
|
0
|
13 ± 0.89
|
18.5 ± 0.5
|
27 ± 0.5
|
21 ± 0.5
|
0
|
24 ± 1.5
|
19.3 ± 1
|
19 ± 0.5
|
25 ± 1.4
|
24 ± 1.5
|
17 ± 0.5
|
25
|
-
|
0
|
MRSA
|
0
|
0
|
0
|
0
|
0
|
0
|
16 ± 1
|
0
|
14 ± 0.5
|
0
|
0
|
0
|
18
|
-
|
0
|
B. cereus ATCC 6633
|
0
|
19 ± 1.78
|
24 ± 1
|
0
|
15 ± 0.5
|
17.5 ± 1
|
0
|
0
|
21 ± 1
|
17 ± 0.2
|
17 ± 0.5
|
14 ± 0.5
|
34
|
-
|
0
|
B. subtilis ATCC 23857
|
21 ± 1
|
0
|
0
|
18 ± 1
|
16 ± 0.5
|
15 ± 0.5
|
0
|
0
|
18 ± 0.5
|
0
|
24 ± 1
|
0
|
29
|
-
|
0
|
E. coli ATCC 20836
|
12.5 ± 0.5
|
0
|
0
|
21 ± 0.5
|
0
|
0
|
13 ± 0.5
|
22 ± 1.5
|
15 ± 0.5
|
26.5 ± 1.17
|
26.5 ± 1.5
|
0
|
30
|
-
|
0
|
P. aeruginosa Clinical isolate
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-
|
0
|
K. pneumonia ATCC 13883
|
11 ± 0.5
|
13 ± 1.8
|
19 ± 1.5
|
0
|
18 ± 0.5
|
18 ± 1.5
|
18.5 ± 1
|
19 ± 1
|
0
|
0
|
22 ± 1
|
13 ± 0.5
|
23
|
-
|
0
|
A. bumanii ATCC 19606
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15 ± 1
|
0
|
0
|
0
|
27
|
-
|
0
|
P. mirabilis ATCC 29906
|
0
|
0
|
0
|
0
|
18 ± 0.5
|
0
|
0
|
0
|
0
|
0
|
15 ± 0.5
|
0
|
28
|
-
|
0
|
A. niger CBS 31.29
|
0
|
16 ± 1.5
|
0
|
0
|
22 ± 1
|
0
|
0
|
0
|
0
|
0
|
15 ± 1.5
|
0
|
-
|
35
|
0
|
C. albicans ATCC 10231
|
18 ± 1
|
0
|
0
|
25 ± 0.5
|
16 ± 0.5
|
15.5 ± 0.5
|
0
|
15 ± 0.5
|
24 ± 1.5
|
30 ± 1.79
|
30 ± 1.5
|
0
|
-
|
33
|
0
|
C. tropicalis ATCC 13803
|
17 ± 1
|
0
|
0
|
18 ± 1
|
0
|
16 ± 0.5
|
0
|
0
|
0
|
0
|
0
|
0
|
-
|
27
|
0
|
P. notatum CBS 673.69
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21 ± 1.5
|
0
|
-
|
30
|
0
|
A. alternate CBS 154.14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-
|
16
|
0
|
S. aureus (Staphylococcus aureus); S epidemidis (Staphylococcus epidemidis); MRSA (methicillin resistant Staphylococcus aureus); B. ceries (Bucillus cerieus); B subtilis (Bucillus subtilis); E. coli (Escherichia coli); P. aeruginosa (Psudomonas aeruginosa); K pneumonia (Klebsiella pneumonia); A bumanii (Acinitobacter bumanii); P. mirabilis (Proteus mirabilis); A. niger (Aspergillus niger); P. notatum (Penicillum notatum); C. albicans (Candida albicans); C. tropicalis (Candida tropicalis); A. alternate (Alternaria alternate). DMSO: - Dimethyle sulfoxide. ATCC: American Type Culture Collection. CBS: Fungal Biodiversity Centre.
2. Minimum Inhibitory Concentration (MIC) of bioactive metabolites from Cladosporium extract with the highest antimicrobial activity.
Minimum Inhibitory Concentrations of Cladosporium extract were ranged from 0.0625 to 1 mg/ml. Strong antimicrobial activity against was observed with C. oxysporum HMA-M2, in which its peak antimicrobial activity was observed against B. subtilis ATCC 23857, C albicans ATCC 10231 and S. aureus ATCC 25923 (0.125 mg/ml). In addition, C. cladosporioides HMA-285 in which its peak antimicrobial activity was observed against S. epidemidis ATCC 12228, S. aureus ATCC 25923 and A. alternate CBS 154.14 (0.125 mg/ml). C. herbarum HMA-N9 showed maximum antimicrobial activity was observed against C albicans ATCC 10231 (0.0625 mg/ml), B. cereus ATCC 6633 (0.0625 mg/ml and S. aureus ATCC 25923 (0.125 mg/ml).
Moderate antimicrobial activity was noticed with C. asterinae HMA-300, in which its highest antimicrobial activity was observed against B. subtilis ATCC 23857 (0.125 mg/ml). In addition, C. cladosporioides HMA-232 that showed highest activity against C. tropicalis ATCC 13803 (0.0625 mg/ml), Likewise, C. cladosporioides HMA-407 where the maximum activity was observed against S. aureus ATCC 25923 (0.0625 mg/ml).
Whereas, mild antimicrobial activity was noticed in C. herbarum HMA-36 extract. Its highest antimicrobial activity was observed against E. coli ATCC 20836 (0.125 mg/ml). Additionally, C. oxysporum HMA-10 exhibited top antimicrobial activity against C albicans ATCC 10231, S epidemidis ATCC 12228 and E. coli ATCC 20836 (0.0625 mg/ml). Furthermore, C. oxysporum HMA-13. Weak antimicrobial activity, was observed with C. uredinicola HMA-59, it showed maximum activity against B. cereus ATCC 6633 (0.125 mg/ml). Besides, C. oxysporum HMA-221 ethyl acetate crude extract that revealed highest activity against K pneumonia ATCC 13883 and B. cereus ATCC 6633 (0.25 mg/ml).
3. High-performance liquid chromatography-diode-array detector (HPLC-DAD) assay for Cladosporium bioactive metabolites
In the current study, High Performance Liquid Chromatography coupled with Diiodoarray Detection (HPLC-DAD) analysis of the fractions with the highest antimicrobial activity against the tested bacteria and fungi, from the extracts of the species C. oxysporum, C. cladosporioides and C. herbarum (that showed the maximum activity) suggested the presence of compounds which may be responsible for the biological activities they elicit.
The HPLC-DAD analysis of the Cladosporium extracts revealed the presence of compounds which may be responsible for the antimicrobial activities they elicit. Two compounds coumarin, citreoisocoumarinol and cladosporin were identified as the major compounds in the extract with code M2, fractions with codes COM2 and COM11 that identified as C. oxysporum. In addition, cladosporin and acropyrone were detected as the major compound in the extract fractions with codes CH-1 and CH-5 that identified as C. herbarum. Nigricinol and Questinol were in the extract of C. cladosporioides HMA-713, fractions with codes CC285-2, CC285-4 and CC285-10 that identified as C. cladosporioides as presented in Figures (2) to (7).
4. Morphological and ultra-structural alterations caused by Cladosporium bioactive metabolites by SEM and TEM
The untreated Staphylococcus aureus ATCC 29213 appeared cocci that displayed normally dividing cells with sharp delineation between cell wall, cytoplasmic membrane and the cytoplasm. After incubation of the bacterial cells with purified antimicrobial compound, dramatic cellular alterations became visible on electron microscopic image. The treated cells appeared oblong; edges become abnormal, elongated. Cell wall disrupted and exhibited thickened in some parts and breakdown in other due to leakage of cytoplasm as shown in Figure (8).
Candida albicans MTCC183 in TEM micrograph of untreated cells. The cytoplasm of control cells appeared homogeneous containing a nucleus, vesicle and mitochondria, surrounded by a defined cell membrane and regular cell wall with a clear periplasm region. When subjected of Candida albicans MTCC183 cells to purified antimicrobial compound, the inner organelles were completely discomposed and even cell membrane and wall were deeply affected and look like undulant. Yeast cells were found collapsed which followed by an outflow of the cytoplasmic component as shown in Figure (9).
Aspergillus niger appeared with rounded conidia in TEM micrograph of untreated cells and showed a continuous thin smooth cell wall, cell membrane and nuclear material. When subjected of Aspergillus niger cells to purified antimicrobial compound, fungal cells lysed rapidly, so cells appeared as very long hyphae as shown in Figure (10 & 11)